Found: 18
Select item for more details and to access through your institution.
Standard Versus Reduced CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: An Observational Multicenter Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 23, p. 7441, doi. 10.3390/jcm13237441
- By:
- Publication type:
- Article
Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review.
- Published in:
- Cancers, 2024, v. 16, n. 23, p. 4082, doi. 10.3390/cancers16234082
- By:
- Publication type:
- Article
Bone marrow of patients with active multiple myeloma: Angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44.
- Published in:
- American Journal of Hematology, 1995, v. 50, n. 1, p. 9, doi. 10.1002/ajh.2830500103
- By:
- Publication type:
- Article
The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 5, p. 842, doi. 10.3390/jpm12050842
- By:
- Publication type:
- Article
The Mediterranean Lifestyle to Contrast Low-Grade Inflammation Behavior in Cancer.
- Published in:
- Nutrients, 2023, v. 15, n. 7, p. 1667, doi. 10.3390/nu15071667
- By:
- Publication type:
- Article
Systemic Treatments for Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Old Certainties and New Frontiers.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2022, v. 29, p. 1, doi. 10.1177/10732748221106267
- By:
- Publication type:
- Article
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3442, doi. 10.3390/cancers16203442
- By:
- Publication type:
- Article
Chronic Inflammation in Obesity and Cancer Cachexia.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 8, p. 2191, doi. 10.3390/jcm11082191
- By:
- Publication type:
- Article
Sorafenib and locoregional deep -hyperthermia in advanced hepatocellular carcinoma: A phase II study.
- Published in:
- Oncology Letters, 2014, v. 8, n. 4, p. 1783, doi. 10.3892/ol.2014.2376
- By:
- Publication type:
- Article
Systemic Treatments for Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Old Certainties and New Frontiers.
- Published in:
- 2022
- By:
- Publication type:
- Book Review
Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes.
- Published in:
- Oncologist, 2016, v. 21, n. 11, p. 1298, doi. 10.1634/theoncologist.2016-0022
- By:
- Publication type:
- Article
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study.
- Published in:
- Medicina (1010660X), 2022, v. 58, n. 11, p. 1543, doi. 10.3390/medicina58111543
- By:
- Publication type:
- Article
Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward.
- Published in:
- Medicina (1010660X), 2022, v. 58, n. 5, p. 600, doi. 10.3390/medicina58050600
- By:
- Publication type:
- Article
The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer.
- Published in:
- Cancer Causes & Control, 2014, v. 25, n. 11, p. 1531, doi. 10.1007/s10552-014-0457-4
- By:
- Publication type:
- Article
Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress.
- Published in:
- Current Oncology, 2022, v. 29, n. 10, p. 7925, doi. 10.3390/curroncol29100626
- By:
- Publication type:
- Article
Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges.
- Published in:
- Current Oncology, 2021, v. 28, n. 5, p. 3393, doi. 10.3390/curroncol28050293
- By:
- Publication type:
- Article
Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 12, p. 1857, doi. 10.3390/cells11121857
- By:
- Publication type:
- Article
Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 9, p. 1146, doi. 10.3390/pharmaceutics16091146
- By:
- Publication type:
- Article